Effects of tetrahydroberberine on peripheral vascular dopamine DA1 and DA2 receptor subtypes

Zhongguo Zhongyao Zazhi

Volumn 25, Issue 8, 2000, Pages 500-

  Zhang, Wei Fang ^a   Zhi, Jian Ming ^a   Guo, Wei ^a   Zhao, Rong Rui ^a   Jin, Guo Zhang ^b  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Dopamine receptor agonist; Dopamine receptor antagonist; Tetrahydroberberine; Vascular dopamine receptor subtypes; Vascular relaxation

Indexed keywords

BERBERINE; CANADINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DRUG DERIVATIVE;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; FEMALE; IN VITRO STUDY; MALE; RABBIT; VASODILATATION;

ANIMALS; BERBERINE; FEMALE; MALE; RABBITS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; VASODILATION;

EID: 23444446417     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. XU Shou-Xi, YU Lei-Ping, HAN Yun-Ru, et al. Effects of Tetrahydroprotoberberines on Dopamine Receptor Subtypes in Brain. Acta Pharmacol Sin, 1989, 10(2):104.
2. 2 Receptor in Ventral Tegmental Area of Rat. Acta Pharmacol Sin, 1997, 18(2):143.
3. Brayden J E. Membrane Hyperpolarization is a Mechanism of Endothelium-dependent Cerebral Vasodilation. Am j Physiol, 1990, 259:H668.
4. Zhu L, Zhao R R, Wang W Z. Comparative Studies on the Characteristics of Dopamine Receptors in Different Vascular Systems. Chin J Physiol Sci, 1995, 11(1):81.
5. Goldberg L I, Kohli J P. Peripheral Dopamine Receptors: a Classification Based on Potency Series and Specific Antagonism. Trends Pharmacol Sci, 1983;4:64.